{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:54:07Z","timestamp":1789959247436,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-05075-8","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:35:56Z","timestamp":1750293356000},"page":"193-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A comprehensive scoring system integrating clinical and radiological variables for the detection of clinically significant prostate cancer on bi-parameter MRI: multi-center comparison with multi-parametric MRI"],"prefix":"10.1007","volume":"51","author":[{"given":"Liqin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"issue":"3","key":"5075_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u2013263. doi: https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5075_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.eururo.2019.02.009","volume":"76","author":"J Hugosson","year":"2019","unstructured":"Hugosson J, Roobol MJ, M\u00e5nsson M, et al. A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer. Eur Urol. 2019;76(1):43\u201351. doi: https:\/\/doi.org\/10.1016\/j.eururo.2019.02.009.","journal-title":"Eur Urol"},{"issue":"6","key":"5075_CR3","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.eururo.2021.09.007","volume":"80","author":"MJ Hagens","year":"2021","unstructured":"Hagens MJ, van Leeuwen PJ. A Future Prebiopsy Imaging-guided Pathway to Safely Omit Systematic Biopsies and Prevent Diagnosis of Indolent Prostate Cancer. Eur Urol. 2021;80(6):690\u2013692. doi: https:\/\/doi.org\/10.1016\/j.eururo.2021.09.007.","journal-title":"Eur Urol"},{"issue":"2","key":"5075_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41391-023-00782-z","volume":"27","author":"S Guo","year":"2024","unstructured":"Guo S, Zhang J, Wang Y, et al. Avoiding unnecessary biopsy: the combination of PRIMARY score with prostate-specific antigen density for prostate biopsy decision. Prostate Cancer Prostatic Dis. 2024;27(2):288\u2013293. doi: https:\/\/doi.org\/10.1038\/s41391-023-00782-z.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"5075_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41585-019-0212-4","volume":"17","author":"A Stabile","year":"2020","unstructured":"Stabile A, Giganti F, Rosenkrantz AB, et al. Multiparametric MRI for prostate cancer diagnosis: current status and future directions. Nat Rev Urol. 2020;17(1):41\u201361. doi: https:\/\/doi.org\/10.1038\/s41585-019-0212-4.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"5075_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13244-023-01421-w","volume":"14","author":"Z Sun","year":"2023","unstructured":"Sun Z, Wang K, Kong Z, et al. A multicenter study of artificial intelligence-aided software for detecting visible clinically significant prostate cancer on mpMRI. Insights Imaging. 2023;14(1):72. doi: https:\/\/doi.org\/10.1186\/s13244-023-01421-w.","journal-title":"Insights Imaging"},{"issue":"9","key":"5075_CR7","doi-asserted-by":"publisher","first-page":"6168","DOI":"10.1007\/s00330-024-10626-6","volume":"34","author":"AR Padhani","year":"2024","unstructured":"Padhani AR, Godtman RA, Schoots IG. Key learning on the promise and limitations of MRI in prostate cancer screening. Eur Radiol. 2024;34(9):6168\u20136174. doi: https:\/\/doi.org\/10.1007\/s00330-024-10626-6.","journal-title":"Eur Radiol"},{"issue":"10","key":"5075_CR8","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1007\/s00261-022-03592-4","volume":"47","author":"X Wei","year":"2022","unstructured":"Wei X, Xu J, Zhong S, et al. Diagnostic value of combining PI-RADS v2.1 with PSAD in clinically significant prostate cancer. Abdom Radiol (NY). 2022;47(10):3574\u20133582. doi: https:\/\/doi.org\/10.1007\/s00261-022-03592-4.","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"5075_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13244-024-01631-w","volume":"15","author":"J Bao","year":"2024","unstructured":"Bao J, Qiao X, Song Y, et al. Prediction of clinically significant prostate cancer using radiomics models in real-world clinical practice: a retrospective multicenter study. Insights Imaging. 2024;15(1):68. doi: https:\/\/doi.org\/10.1186\/s13244-024-01631-w.","journal-title":"Insights Imaging"},{"key":"5075_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.29268","author":"MJ Kim","year":"2024","unstructured":"Kim MJ, Park JJ, Kang KA, et al. Utility of Prostate Health Index Density for Biopsy Strategy in Biopsy-Na\u00efve Patients With PI-RADS v2.1 Category 3 Lesions. J Magn Reson Imaging. 2024. doi: https:\/\/doi.org\/10.1002\/jmri.29268.","journal-title":"J Magn Reson Imaging"},{"key":"5075_CR11","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.17.19014","author":"M Scialpi","year":"2018","unstructured":"Scialpi M, Aisa MC, D\u2019Andrea A, et al. Simplified Prostate Imaging Reporting and Data System for Biparametric Prostate MRI: A Proposal. AJR Am J Roentgenol. 2018;211(2):379\u2013382. doi: https:\/\/doi.org\/10.2214\/AJR.17.19014."},{"key":"5075_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.02.033","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol. 2019;76(3):340\u2013351. doi: https:\/\/doi.org\/10.1016\/j.eururo.2019.02.033."},{"issue":"2","key":"5075_CR13","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/s00261-022-03750-8","volume":"48","author":"J Song","year":"2023","unstructured":"Song J, Zhao C, Zhang F, et al. The diagnostic performance in clinically significant prostate cancer with PI-RADS version 2.1: simplified bpMRI versus standard mpMRI. Abdom Radiol (NY). 2023;48(2):704\u2013712. doi: https:\/\/doi.org\/10.1007\/s00261-022-03750-8.","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"5075_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jmri.27283","volume":"53","author":"T Tamada","year":"2021","unstructured":"Tamada T, Kido A, Yamamoto A, et al. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1. J Magn Reson Imaging. 2021;53(1):283\u2013291. doi: https:\/\/doi.org\/10.1002\/jmri.27283.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"5075_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.21873\/anticanres.16163","volume":"43","author":"M Scialpi","year":"2023","unstructured":"Scialpi M, Martorana E, Scialpi P, et al. S-PI-RADS and PI-RRADS for Biparametric MRI in the Detection of Prostate Cancer and Post-treatment Local Recurrence. Anticancer Res. 2023;43(1):297\u2013303. doi: https:\/\/doi.org\/10.21873\/anticanres.16163.","journal-title":"Anticancer Res"},{"key":"5075_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.clinimag.2021.06.024","volume":"88","author":"G Wang","year":"2022","unstructured":"Wang G, Yu G, Chen J, et al. Can high b-value 3.0 T biparametric MRI with the Simplified Prostate Image Reporting and Data System (S-PI-RADS) be used in biopsy-na\u00efve men? Clin Imaging. 2022;88:80\u201386. doi: https:\/\/doi.org\/10.1016\/j.clinimag.2021.06.024.","journal-title":"Clin Imaging"},{"key":"5075_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.clinimag.2022.11.013","volume":"94","author":"M Scialpi","year":"2023","unstructured":"Scialpi M, Martorana E, Torre R, et al. Index lesion detection in multifocal prostate cancer: Simplified PI-RADS biparametric MRI vs PI-RADS v2.1 multiparametric MRI. Clin Imaging. 2023;94:108\u2013115. doi: https:\/\/doi.org\/10.1016\/j.clinimag.2022.11.013.","journal-title":"Clin Imaging"},{"key":"5075_CR18","doi-asserted-by":"publisher","unstructured":"Epstein JI, Egevad L, Amin MB, er al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol. 2016;40(2):244\u2013\u200952. doi: https:\/\/doi.org\/10.1097\/PAS.0000000000000530.","DOI":"10.1097\/PAS.0000000000000530"},{"issue":"8","key":"5075_CR19","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1007\/s00261-024-04345-1","volume":"49","author":"HW Moon","year":"2024","unstructured":"Moon HW, Kim DH, Kim J, et al. A preoperative scoring system for predicting the extraprostatic extension of prostate cancer following radical prostatectomy using magnetic resonance imaging and clinical factors. Abdom Radiol (NY). 2024;49(8):2683\u20132692. doi: https:\/\/doi.org\/10.1007\/s00261-024-04345-1.","journal-title":"Abdom Radiol (NY)"},{"issue":"9","key":"5075_CR20","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.5858\/arpa.2019-0117-LE","volume":"143","author":"S Ferraro","year":"2019","unstructured":"Ferraro S, Caruso S, Panteghini M. Reflex Testing of Free Prostate-Specific Antigen as Effective Health Care Policy. Arch Pathol Lab Med. 2019;143(9):1045. doi: https:\/\/doi.org\/10.5858\/arpa.2019-0117-LE.","journal-title":"Arch Pathol Lab Med"},{"issue":"22","key":"5075_CR21","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1056\/NEJMoa031918","volume":"350","author":"IM Thompson","year":"2004","unstructured":"Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level\u2009<\u2009or =\u20094.0 ng per milliliter. N Engl J Med. 2004;350(22):2239\u201346. doi: https:\/\/doi.org\/10.1056\/NEJMoa031918.","journal-title":"N Engl J Med"},{"issue":"7","key":"5075_CR22","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1515\/cclm-2023-0008","volume":"61","author":"S Ferraro","year":"2023","unstructured":"Ferraro S, Biganzoli D, Rossi RS, et al. Individual risk prediction of high grade prostate cancer based on the combination between total prostate-specific antigen (PSA) and free to total PSA ratio. Clin Chem Lab Med. 2023;61(7):1327\u20131334. doi: https:\/\/doi.org\/10.1515\/cclm-2023-0008.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"5075_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/bju.13649","volume":"120","author":"E Martorana","year":"2017","unstructured":"Martorana E, Pirola GM, Scialpi M, et al. Lesion volume predicts prostate cancer risk and aggressiveness: validation of its value alone and matched with prostate imaging reporting and data system score. BJU Int. 2017;120(1):92\u2013103. doi: https:\/\/doi.org\/10.1111\/bju.13649.","journal-title":"BJU Int"},{"issue":"4","key":"5075_CR24","doi-asserted-by":"publisher","first-page":"e221309","DOI":"10.1148\/radiol.221309","volume":"307","author":"EC Yilmaz","year":"2023","unstructured":"Yilmaz EC, Shih JH, Belue MJ, et al. Prospective Evaluation of PI-RADS Version 2.1 for Prostate Cancer Detection and Investigation of Multiparametric MRI-derived Markers. Radiology. 2023;307(4):e221309. doi: https:\/\/doi.org\/10.1148\/radiol.221309.","journal-title":"Radiology"},{"issue":"1","key":"5075_CR25","doi-asserted-by":"publisher","first-page":"e240041","DOI":"10.1148\/radiol.240041","volume":"313","author":"DD Yang","year":"2024","unstructured":"Yang DD, Lee LK, Tsui JMG, et al. AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer. Radiology. 2024;313(1):e240041. doi: https:\/\/doi.org\/10.1148\/radiol.240041.","journal-title":"Radiology"},{"issue":"1","key":"5075_CR26","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1186\/s12885-023-11306-2","volume":"23","author":"Z Chen","year":"2023","unstructured":"Chen Z, Zhang J, Jin D, et al. A novel clinically significant prostate cancer prediction system with multiparametric MRI and PSA: P.Z.A. score. BMC Cancer. 2023;23(1):1138. doi: https:\/\/doi.org\/10.1186\/s12885-023-11306-2.","journal-title":"BMC Cancer"},{"key":"5075_CR27","doi-asserted-by":"publisher","unstructured":"Smani S, Jalfon M, Sundaresan V, et al. Inter-reader reliability and diagnostic accuracy of PI-RADS scoring between academic and community care networks: How wide is the gap? Urol Oncol. 2024:S1078-1439(24)00681-1. doi: https:\/\/doi.org\/10.1016\/j.urolonc.2024.10.002.","DOI":"10.1016\/j.urolonc.2024.10.002"},{"issue":"1","key":"5075_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ultrasmedbio.2017.09.012","volume":"44","author":"R Guo","year":"2018","unstructured":"Guo R, Lu G, Qin B, et al. Ultrasound Imaging Technologies for Breast Cancer Detection and Management: A Review. Ultrasound Med Biol. 2018;44(1):37\u201370. doi: https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2017.09.012.","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"5075_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiol.2017171240","volume":"287","author":"FN Tessler","year":"2018","unstructured":"Tessler FN, Middleton WD, Grant EG. Thyroid Imaging Reporting and Data System (TI-RADS): A User\u2019s Guide. Radiology. 2018;287(1):29\u201336. doi: https:\/\/doi.org\/10.1148\/radiol.2017171240.","journal-title":"Radiology"},{"key":"5075_CR30","doi-asserted-by":"publisher","unstructured":"Cornford P, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2024;86(2):148\u2013163. doi: https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027.","DOI":"10.1016\/j.eururo.2024.03.027"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05075-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05075-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05075-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:03:58Z","timestamp":1769148238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05075-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["5075"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05075-8","relation":{"references":[{"id-type":"doi","id":"10.2214\/AJR.17.19014","asserted-by":"subject"},{"id-type":"doi","id":"10.1016\/j.eururo.2019.02.033","asserted-by":"subject"}]},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}